vs
Side-by-side financial comparison of Consolidated Water Co. Ltd. (CWCO) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($60.1M vs $29.6M, roughly 2.0× Consolidated Water Co. Ltd.). Consolidated Water Co. Ltd. runs the higher net margin — 10.3% vs -92.6%, a 102.8% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (83.8% vs 4.4%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (43.8% CAGR vs -13.6%).
Coca-Cola Consolidated, Inc., headquartered in Charlotte, North Carolina, is the largest independent Coca-Cola bottler in the United States.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
CWCO vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $29.6M | $60.1M |
| Net Profit | $3.0M | $-55.6M |
| Gross Margin | 34.7% | 88.1% |
| Operating Margin | 9.1% | -87.1% |
| Net Margin | 10.3% | -92.6% |
| Revenue YoY | 4.4% | 83.8% |
| Net Profit YoY | 91.5% | — |
| EPS (diluted) | $0.18 | $-0.83 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $60.1M | ||
| Q4 25 | $29.6M | $57.3M | ||
| Q3 25 | $35.1M | $51.3M | ||
| Q2 25 | $33.6M | $48.5M | ||
| Q1 25 | $33.7M | $32.7M | ||
| Q4 24 | $28.4M | $41.8M | ||
| Q3 24 | $33.4M | $33.3M | ||
| Q2 24 | $32.5M | $29.1M |
| Q1 26 | — | $-55.6M | ||
| Q4 25 | $3.0M | $-47.5M | ||
| Q3 25 | $5.5M | $-52.9M | ||
| Q2 25 | $5.1M | $-46.6M | ||
| Q1 25 | $4.8M | $-49.5M | ||
| Q4 24 | $1.6M | $-43.3M | ||
| Q3 24 | $4.5M | $-43.6M | ||
| Q2 24 | $15.9M | $-32.3M |
| Q1 26 | — | 88.1% | ||
| Q4 25 | 34.7% | 91.6% | ||
| Q3 25 | 36.9% | 89.3% | ||
| Q2 25 | 38.2% | 88.6% | ||
| Q1 25 | 36.5% | 88.8% | ||
| Q4 24 | 29.9% | 90.9% | ||
| Q3 24 | 34.8% | 88.5% | ||
| Q2 24 | 35.8% | 89.9% |
| Q1 26 | — | -87.1% | ||
| Q4 25 | 9.1% | -82.2% | ||
| Q3 25 | 16.4% | -102.6% | ||
| Q2 25 | 15.7% | -93.4% | ||
| Q1 25 | 13.7% | -143.7% | ||
| Q4 24 | 3.8% | -98.6% | ||
| Q3 24 | 14.6% | -132.0% | ||
| Q2 24 | 15.4% | -139.2% |
| Q1 26 | — | -92.6% | ||
| Q4 25 | 10.3% | -83.0% | ||
| Q3 25 | 15.8% | -103.1% | ||
| Q2 25 | 15.2% | -96.1% | ||
| Q1 25 | 14.2% | -151.4% | ||
| Q4 24 | 5.6% | -103.6% | ||
| Q3 24 | 13.3% | -131.2% | ||
| Q2 24 | 48.8% | -110.9% |
| Q1 26 | — | $-0.83 | ||
| Q4 25 | $0.18 | $-0.73 | ||
| Q3 25 | $0.34 | $-0.82 | ||
| Q2 25 | $0.32 | $-0.75 | ||
| Q1 25 | $0.30 | $-0.81 | ||
| Q4 24 | $0.10 | $-0.71 | ||
| Q3 24 | $0.28 | $-0.73 | ||
| Q2 24 | $0.99 | $-0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $123.8M | $340.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $221.7M | $122.9M |
| Total Assets | $257.6M | $442.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $340.6M | ||
| Q4 25 | $123.8M | $388.9M | ||
| Q3 25 | $123.6M | $416.1M | ||
| Q2 25 | $112.2M | $291.0M | ||
| Q1 25 | $107.9M | $314.5M | ||
| Q4 24 | $99.4M | $320.6M | ||
| Q3 24 | $104.9M | $298.4M | ||
| Q2 24 | $96.7M | $319.1M |
| Q1 26 | — | $122.9M | ||
| Q4 25 | $221.7M | $139.1M | ||
| Q3 25 | $220.4M | $148.8M | ||
| Q2 25 | $216.6M | $-11.9M | ||
| Q1 25 | $213.3M | $18.9M | ||
| Q4 24 | $210.0M | $21.7M | ||
| Q3 24 | $209.8M | $11.2M | ||
| Q2 24 | $206.7M | $39.3M |
| Q1 26 | — | $442.3M | ||
| Q4 25 | $257.6M | $480.2M | ||
| Q3 25 | $257.2M | $506.9M | ||
| Q2 25 | $257.5M | $372.7M | ||
| Q1 25 | $250.4M | $386.7M | ||
| Q4 24 | $243.3M | $392.3M | ||
| Q3 24 | $238.4M | $363.6M | ||
| Q2 24 | $235.2M | $381.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.8M | — |
| Free Cash FlowOCF − Capex | $3.4M | — |
| FCF MarginFCF / Revenue | 11.4% | — |
| Capex IntensityCapex / Revenue | 8.1% | — |
| Cash ConversionOCF / Net Profit | 1.90× | — |
| TTM Free Cash FlowTrailing 4 quarters | $33.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $5.8M | $-25.4M | ||
| Q3 25 | $15.4M | $-26.6M | ||
| Q2 25 | $8.8M | $-23.3M | ||
| Q1 25 | $11.8M | $-40.4M | ||
| Q4 24 | $-742.0K | $-18.8M | ||
| Q3 24 | $10.4M | $-25.2M | ||
| Q2 24 | $21.0M | $-29.1M |
| Q1 26 | — | — | ||
| Q4 25 | $3.4M | — | ||
| Q3 25 | $13.5M | — | ||
| Q2 25 | $6.1M | — | ||
| Q1 25 | $10.2M | — | ||
| Q4 24 | $-3.7M | — | ||
| Q3 24 | $8.3M | — | ||
| Q2 24 | $19.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | 11.4% | — | ||
| Q3 25 | 38.4% | — | ||
| Q2 25 | 18.3% | — | ||
| Q1 25 | 30.1% | — | ||
| Q4 24 | -13.0% | — | ||
| Q3 24 | 24.9% | — | ||
| Q2 24 | 60.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | — | ||
| Q3 25 | 5.5% | — | ||
| Q2 25 | 7.8% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 6.1% | — | ||
| Q2 24 | 3.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.90× | — | ||
| Q3 25 | 2.79× | — | ||
| Q2 25 | 1.72× | — | ||
| Q1 25 | 2.45× | — | ||
| Q4 24 | -0.47× | — | ||
| Q3 24 | 2.32× | — | ||
| Q2 24 | 1.32× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CWCO
| Services Revenues | $10.5M | 35% |
| Transferred At Point In Time | $8.5M | 29% |
| Operations And Maintenance | $8.4M | 28% |
| Transferred Over Time | $1.9M | 7% |
RYTM
Segment breakdown not available.
